Positron emission tomography in the detection of occult primary head and neck carcinoma: A retrospective study

Head and Neck Oncology

Volumn 4, Issue 1, 2012, Pages

  Pereira, Gabriel ^a   Silva, Joaquim Castro ^b   Monteiro, Eurico ^b  

^a Braga Hospital   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Fluorodeoxyglucose; Head and neck carcinoma; Metastases; Positron emission tomography; Unknown primary tumor

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISTANT METASTASIS; ESOPHAGUS CARCINOMA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LIVER METASTASIS; LUNG CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; OCCULT CANCER; OROPHARYNX CARCINOMA; PAROTID GLAND CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TONGUE CARCINOMA; TONSIL CARCINOMA; TUMOR BIOPSY; WHOLE BODY PET;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 84862260887     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-4-34     Document Type: Article

References (17)

1. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Rusthoven KE, Koshy M, Paulino AC, Cancer 2004 101 2641 2649 10.1002/cncr.20687 15517576
2. Evaluation and management of malignant cervical lymphadenopathy with an unknown primary tumor. Mahoney EJ, Spiegel JH, Otolaryngol Clin N Am 2005 38 87 97 10.1016/j.otc.2004.10.014
3. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Di Martino E, Nowak B, Hassan HA, Hausmann R, Adam G, Buell U, Westhofen M, Arch Otolaryngol Head Neck Surg 2000 126 1457 1461 11115282
4. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Greven KM, Williams DW, McGuirt WF, Harkness BA, DAgostino RB, Keyes JW, Watson NE, Head Neck 2001 23 942 946 10.1002/hed.1136 11754497
5. 2[F]-Fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Jungehulsing M, Scheidhauer K, Damm H, Pietrzyk U, Eckel H, Schicha H, Stennert E, Otolaryngol Head Neck Surg 2000 123 294 301 10.1067/mhn.2000.104807 10964310
6. 18F-Fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Stokkel MP, Moons KG, ten Broek FW, van Rijk PP, Hordijk GJ, Cancer 1999 86 2370 2377 10.1002/(SICI)1097-0142(19991201)86:11<2370::AID-CNCR27>3.0. CO;2-B 10590380
7. PET in face and neck tumours. Rankin SC, Cancer Imaging 2006 6 89 S95 10.1102/1470-7330.2006.9016 17114083
8. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Aassar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Price DC, Singer MI, Dillon WP, Hawkins RA, Radiology 1999 210 177 181 9885604
9. Detection of unknown occult primary tumors using positron emission tomography. Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenbburg JL, Vaalburg W, Vermey A, Cancer 1998 82 1160 1166 10.1002/(SICI)1097-0142(19980315) 82:6<1160::AID-CNCR22>3.0.CO;2-3 9506364
10. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM, Radiology 2004 231 65 72 10.1148/radiol.2311030271 14990824
11. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose. Greven KM, Keyes JW, Williams DW, McGuirt WF, Joyce WT, Cancer 1999 86 114 118 10.1002/(SICI)1097-0142(19990701)86:1<114::AID-CNCR16>3.0.CO;2-E 10391570
12. Positron emission tomography in the management of unknown primary head and neck carcinoma. Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA, Arch Otolaryngol Head Neck Surg 2005 131 626 629 10.1001/archotol.131.7.626 16027287
13. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ, Head Neck 1998 20 739 744 10.1002/(SICI)1097-0347(199812)20:8<739::AID-HED13>3.0.CO;2-0 9790297
14. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Koch WM, Bhatti N, Williams MF, Eisele DW, Otolaryngol Head Neck Surg 2001 124 331 333 10.1067/mhn.2001.114309 11241001
15. Occult tonsillar carcinoma in the unknown primary. McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM, Laryngoscope 1998 108 1605 1610 10.1097/00005537-199811000-00004 9818813
16. Management of unknown primary tumor. Chepeha D, Koch W, Pitman K, Head Neck 2003 6 499 504
17. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Fogarty GB, Peters LJ, Stewart J, Scott C, Rischin D, Hicks RJ, Head Neck 2003 25 138 145 10.1002/hed.10191 12509797